loader2
Partner With Us NRI

Company details

255.00
267.40
255.00
414.75
6M Return -21.37%
1Y Return -10.33%
Mkt Cap.(Cr) 531.90
Volume 5,578
Div Yield 0.57%
OI
-
OI Chg %
-
Volume 5,578

Open Free Demat Account Online with ICICIDIRECT

SWOT

  • swot

  • technicals

  • deals

  • shareholding


EMA SMA

Delivery and volume

Financials

  • Profit and loss statement

  • Balance sheet

  • Quarterly Result

  • Ratio

Sales(Cr.)

Operating Profit(Cr.)

Profit after Tax(Cr.)

Equity

Reserves and Surplus

Debt

Sales

Operating Profit

Profit after tax

PE

Debt/Equity

P BV

INSIDER & INSTITUIONAL ACTIVITY

Equity Capital: 375.29 Cr FV: 10.00
Period MF Net Purchase / (sold) FII Net
LAST 1M 24,153.35 -39,474.21
LAST 3M 70,482.80 -53,901.04
LAST 6M 141,118.09 -188,404.80
LAST 12M 210,965.84 -182,647.76

Information

  • About Company
  • Company Info
  • Listing Info
7.64
42.05%
216.1186
24.29%
18.09%
Description
  • Lincoln Pharmaceuticals, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a partnership firm in Jan 1979 to manufacture pharmaceutical formulations was converted into a public limited company in Jan. `95. All the assets and business of the erstwhile partnership was transferred to the company. The company was carrying on its business by getting its products manufactured on loan licence basis from 1979 to 1982. It then set up its own manufacturing facilities at Naroda, Gujarat for manufacturing tablets, capsules, liquid and powder syrups and, ointments. It is also getting its products manufactured on loan licence basis from other manufacturers to meet the demand of small volume parenterals. The company has set up a modern formulation manufacturing plant at Khatraj (Mehsana district), Gujarat, to manufacture small volume parenterals like dry powder injectables, liquid vial, liquid ampoules and eye drops and expand its production capacities of the existing products. It is also in the process of establishing a fully equipped laboratory to undertake in-house testing of its products for better quality control and R&D. It came out with a public issue in Feb.`96 to part-finance its project. In 2000-01 the company has been granted ISO 9002 certificate and WHO registration.

Read More

Registered Address

Lincoln House B/H Satyam Compe, Science City Road Sola, Ahmedabad, Gujarat, 380060

Tel : 91-079-67778000
Email : info:lincolnpharma.com
Website : http://www.lincolnpharma.com

Registrar

Sharepro Services India Pvt Lt

AGM Date (Month) : Sep
Face Value Equity Shares : 10
Market Lot Equity Shares : 1
BSE Code : 531633
NSE Code : LINCOLN
Book Closure Date (Month) : Sep
BSE Group : A
ISIN : INE405C01035

ICICIdirect Lincoln Pharmaceuticals Ltd FAQ

You can buy Lincoln Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy Lincoln Pharmaceuticals Ltd Share.
Company share prices and volatile and keep changing according to the market conditions. As of May 26, 2022 04:01 PM the closing price of Lincoln Pharmaceuticals Ltd was ₹ 265.55.
Market capitalization or market cap is determined by multiplying the current market price of a company’s shares with the total number of shares outstanding. As of May 26, 2022 04:01 PM, the market cap of Lincoln Pharmaceuticals Ltd stood at ₹ 531.90.
The latest PE ratio of Lincoln Pharmaceuticals Ltd as of May 26, 2022 04:01 PM is 7.64
The latest PB ratio of Lincoln Pharmaceuticals Ltd as of May 26, 2022 04:01 PM is 0.81
The 52-week high of Lincoln Pharmaceuticals Ltd is ₹ 414.75 while the 52-week low is ₹ 255.00 .

Thank you for subscribing to Equity/ Equity Research/MF/FnO Newsletter. You will hear from us shortly.

for your vote

CLOSE